Infusion Pumps: Technology and Market 2012-2022


February 16, 2012
140 Pages - SKU: VSG3823840
License type:
Infusion Pumps: Technology and Market 2012-2022

  enlarge


Our new report Infusion Pumps: Technology and Market 2012-2022 covers the trends in the infusion pumps market, a promising segment of the drug delivery sector. The traditional gravity controlled infusion pumps have been used extensively. The electronic infusion pumps have also been available in the market since long, but only beginning to see increased adoption. The use of infusion pumps is advantageous for the healthcare providers as well as the patients specifically for conditions such as diabetes, delivery of analgesics in cancer patients or post-surgery, delivery of chemotherapy drugs and enteral feeding in patients with feeding disorders. As the technology becomes more advanced, the infusion pumps are becoming smaller in size, wireless, and more convenient to use. Combined with the ability of the infusion pumps to deliver precisely measured dose are the right intervals, the infusion pumps allow the patients to carry out their normal activities, and reduce the hospital stay and visits. According to our latest pharma report - the global infusion pumps market will be worth $9.5bn by 2016.

Infusion Pumps: Technology and Market 2012-2022 report forecasts the size and value of leading national/regional markets: North America, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period. The use of infusion pumps is still more prevalent in the developed regions of North America and Europe, essentially owing to the fact that the infusion pump technology is expensive when compared to the competing technologies. The cost of insulin pumps is covered under Medicare in the US and through private insurance in Canada. However, there are huge opportunities for infusion pump manufacturers in the developing economies of India and China where the use of electronic infusion pumps is limited at present. The report discusses the future technological development that will make the infusion pumps more attractive to the patients and drive their adoption.

Infusion Pumps: Technology and Market 2012-2022 also examines the challenges facing the sector critically, including the high cost and safety issues. The report is developed through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses and a review of companies and leading products.

Why you should buy Infusion Pumps: Technology and Market 2012-2022

In this report, you will receive the following benefits in particular:
  • You will receive our assessment of the current market for infusion pumps, with respect to the leading segments, products, companies and national markets
  • You will discover sales trends for the overall infusion pumps market from 2011 to 2022 - seeing where commercial growth will occur
  • You will discover sales trends for the main segments - insulin pumps and enteral feeding pumps - from 2011 to 2022, with detailed discussions of market potential
  • You will receive sales forecasts for leading national/regional markets (North America, Japan, Europe, India and China), with informed discussion
  • You will assess leading manufacturers and products in the leading segments of the infusion pumps market, with information on the pipeline products
  • You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the infusion pumps market from 2012 onwards
  • You will be able to investigate competition and opportunities influencing the infusion pumps technology for drug delivery from 2012 onwards
  • You will see what will stimulate and restrain the market from 2012
  • You will discover the unmet needs in the market, driving the growth from 2012 onwards.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


Additional Information


Report Excerpt

4.2.1.7 Other Notable Products

In February 2012, a UK based medical device company, Cellnovo, launched their diabetes management system in the UK. The diabetes management system comprises an insulin pump and a handset. The commercial launch of this device will bring the much awaited technological advancement to the diabetes management market – remote monitoring of the patient data. The Cellnovo system is currently being tested in a usability trial in the UK involving 100 patients.

Companies Listed

Abbott Laboratories
Abbott Nutrition
AcelRX
Acura Pharmaceuticals
Alcare Inc
ALCOR Scientific
Alkemes
Animas Corporation
Aradigm
ART Healthcare
Asante Solution
AstraZeneca
B.Braun
Baxter
BioDelivery Sciences
Boston University
Calibra Medical
Cambridge University
Cardinal Health
CareFusion Corporation
Celegene
Cellnovo
Center for Devices and Radiological Health (CDRH)
CeQur
China Aoxing
Codman & Shurtleff Inc
Covidien
D Medical Industries
Danone
Debiotech
DePuy
Diagnostic Systems
Disetronic
Dorn Veterans Administration Medical Center
DURECT
Eli Lilly
Emisphere
FDA
FDA MedWatch
Fresenius Kabi
Generex Biotechnology Corporation
GlaxoSmithKline (GSK)
Glycologic
Hospira
IBM
Insulet
Intercell
Johnson and Johnson (J&J)
Juvenile Diabetes Research Foundation (JDRF)
King Pharmaceuticals
MEDINGO Ltd
Medtronic
Micrus Endovascular
Moog
Nestle Healthcare
NiliMEDIX
Nipro Diagnostics
Novartis
Noven Pharmaceuticals
Novo Nordisk
Nutricia
Oregon Health & Science University
OST Medical
Pacira Pharmaceuticals
Pain Therapeutics
PAION
Pfizer
Pharmaco-Kinesis Corporation
pSivida Corporation
Purdue Pharma
Q Core Medical
QRx Pharmaceuticals
Roche
Roche Diagnostics
Sanofi-Aventis
Sansum Diabetes Research Institute
Shire Pharmaceuticals
SIGMA Spectrum
Smith Group Plc
Smith Medical
SOOIL
Spring
ST Microelectronics
Stanford University
Summit Medical Products
Takeda
Tandem Diabetes Care
Titan Pharmaceuticals
Valeritas
Vectura
WalkMed Infusion